Next Article in Journal
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept
Next Article in Special Issue
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Previous Article in Journal
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
Open AccessArticle

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons

Istituto di ricerche Farmacologiche "Mario Negri", Via La Masa 19, 20156 Milano, Italy
UMR 7102 Neurobiologie des Processus Adaptatifs, Universite P. et M. Curie, 9 quai St Bernard, 75005, Paris, France
Dipartimento Scienze Farmacologiche, Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milano, Italy
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(1), 42-58;
Received: 23 October 2009 / Revised: 3 December 2009 / Accepted: 5 January 2010 / Published: 7 January 2010
(This article belongs to the Special Issue Protein Kinase Inhibitors)
The phosphorylation of Amyloid Precursor Protein (APP) at Thr668 plays a key role in APP metabolism that is highly relevant to AD. The c-Jun-N-terminal kinase (JNK), glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent kinase 5 (Cdk5) can all be responsible for this phosphorylation. These kinases are activated by excitotoxic stimuli fundamental hallmarks of AD. The exposure of cortical neurons to a high dose of NMDA (100 μM) for 30’-45’ led to an increase of P-APP Thr668. During NMDA stimulation APP hyperphosphorylation has to be assigned to GSK-3β activity, since addition of L803-mts, a substrate competitive inhibitor of GSK-3β reduced APP phosphorylation induced by NMDA. On the contrary, inhibition of JNK and Cdk5 with D-JNKI1 and Roscovitine respectively did not prevent NMDA-induced P-APP increase. These data show a tight connection, in excitotoxic conditions, between APP metabolism and the GSK-3β signaling pathway. View Full-Text
Keywords: APP; NMDA; GSK-3β; JNK; Cdk5 APP; NMDA; GSK-3β; JNK; Cdk5
Show Figures

Figure 1

MDPI and ACS Style

Ploia, C.; Sclip, A.; Colombo, A.; Repici, M.; Gardoni, F.; Di Luca, M.; Forloni, G.; Antoniou, X.; Borsello, T. Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons. Pharmaceuticals 2010, 3, 42-58.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop